Antibody molecules to CD73 and uses thereof
US11312783B2 · kind B2 · utility
1Cited by
8References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 21, 2018 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Feb 10, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.